| 12084472 |
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
Jason G. Lewis, Michael R. Leadbetter, Jeremy Caldwell, Dean R. Dragoli, Jeffrey W. Jacobs +4 more |
2024-09-10 |
$26,999,000 |
| 12016856 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Dominique Charmot, Marc Navre, Christopher Carreras, Michael R. Leadbetter, Jeffrey W. Jacobs |
2024-06-25 |
$26,595,000 |
| 11318129 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Dominique Charmot, Marc Navre, Christopher Carreras, Michael R. Leadbetter, Jeffrey W. Jacobs |
2022-05-03 |
$3,420,000 |
| 10968246 |
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
Jason G. Lewis, Michael R. Leadbetter, Jeremy Caldwell, Dean R. Dragoli, Jeffrey W. Jacobs +4 more |
2021-04-06 |
$9,367,000 |
| 10543207 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Dominique Charmot, Marc Navre, Christopher Carreras, Michael R. Leadbetter, Jeffrey W. Jacobs |
2020-01-28 |
$15,420,000 |
| 10392413 |
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
Jason G. Lewis, Michael R. Leadbetter, Jeremy Caldwell, Dean R. Dragoli, Jeffrey W. Jacobs +4 more |
2019-08-27 |
$3,326,000 |
| 10385024 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Christopher Carreras, Dominique Charmot, Tao Chen, Michael R. Leadbetter, Jeffrey W. Jacobs +1 more |
2019-08-20 |
$3,346,000 |
| 10376481 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Christopher Carreras, Michael R. Leadbetter, Jason G. Lewis, Jeffrey W. Jacobs, Irina DOTSENKO +4 more |
2019-08-13 |
$1,912,000 |
| 9408840 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder |
Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2016-08-09 |
$7,926,000 |
| 9301951 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2016-04-05 |
$5,562,000 |
| 9289430 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2016-03-22 |
$2,576,000 |
| 9289429 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2016-03-22 |
$2,576,000 |
| 9278102 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2016-03-08 |
$5,895,000 |
| 9006281 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2015-04-14 |
$5,257,000 |
| 8969377 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2015-03-03 |
$7,073,000 |
| 8916569 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2014-12-23 |
$9,357,000 |
| 8815910 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2014-08-26 |
$2,218,000 |
| 8815908 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2014-08-26 |
$2,218,000 |
| 8809339 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Han-Ting Chang +5 more |
2014-08-19 |
$3,851,000 |
| 8541448 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Dominique Charmot, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre, Christopher Carreras |
2013-09-24 |
|